Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertrand Lioger

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Clinical and Experimental Rheumatology|September 29, 2015
Posterior reversible encephalopathy syndrome and systemic vasculitis: report of six casesBertrand Lioger, Elisabeth Diot, Michael Ebbo, et al.
British Journal of Clinical Pharmacology|February 24, 2017
Antigenic burden and serum IgG concentrations influence rituximab pharmacokinetics in rheumatoid arthritis patientsBertrand Lioger, Soujanya Ratna Edupuganti, Denis Mulleman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 16, 2016
Thymic Epithelial Tumor-Associated Cytopenia: A 10-Year Observational Study in FranceClaire Rivoisy, Benjamin Besse, Nicolas Girard, et al.
The Journal of Rheumatology|August 3, 2019
Rituximab-associated Vasculitis Flare: Incidence, Predictors, and OutcomeAnne Claire Desbois, Lucie Biard, Damien Sène, et al.
American Journal of Hematology|December 17, 2017
Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adultsAlexandra Serris, Zahir Amoura, Florence Canouï-Poitrine, et al.
La Revue De Medecine Interne|June 9, 2024
[The Green group of the French society of internal medicine]Yann Nguyen, Adrien Michon, Bertrand Lioger, et al.
British Journal of Haematology|May 11, 2022
Characteristics, management and outcome of acquired amegakaryocytic thrombocytopeniaAnais Roeser, Guillaume Moulis, Mikael Ebbo, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 21, 2015
Emergence of community-acquired Clostridium difficile infection: the experience of a French hospital and review of the literatureMaja Ogielska, Philippe Lanotte, Cécile Le Brun, et al.
American Journal of Hematology|October 30, 2020
High dose romiplostim as a rescue therapy for adults with severe bleeding and refractory immune thrombocytopeniaMathilde Roumier, Sébastien Le Burel, Sylvain Audia, et al.
Rheumatology (Oxford, England)|May 15, 2018
Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonistsZelie Guitton, Louis Terriou, Jean-Christophe Lega, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Clinical and Experimental Rheumatology|September 29, 2015
Posterior reversible encephalopathy syndrome and systemic vasculitis: report of six casesBertrand Lioger, Elisabeth Diot, Michael Ebbo, et al.
British Journal of Clinical Pharmacology|February 24, 2017
Antigenic burden and serum IgG concentrations influence rituximab pharmacokinetics in rheumatoid arthritis patientsBertrand Lioger, Soujanya Ratna Edupuganti, Denis Mulleman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 16, 2016
Thymic Epithelial Tumor-Associated Cytopenia: A 10-Year Observational Study in FranceClaire Rivoisy, Benjamin Besse, Nicolas Girard, et al.
The Journal of Rheumatology|August 3, 2019
Rituximab-associated Vasculitis Flare: Incidence, Predictors, and OutcomeAnne Claire Desbois, Lucie Biard, Damien Sène, et al.
American Journal of Hematology|December 17, 2017
Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adultsAlexandra Serris, Zahir Amoura, Florence Canouï-Poitrine, et al.
La Revue De Medecine Interne|June 9, 2024
[The Green group of the French society of internal medicine]Yann Nguyen, Adrien Michon, Bertrand Lioger, et al.
British Journal of Haematology|May 11, 2022
Characteristics, management and outcome of acquired amegakaryocytic thrombocytopeniaAnais Roeser, Guillaume Moulis, Mikael Ebbo, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 21, 2015
Emergence of community-acquired Clostridium difficile infection: the experience of a French hospital and review of the literatureMaja Ogielska, Philippe Lanotte, Cécile Le Brun, et al.
American Journal of Hematology|October 30, 2020
High dose romiplostim as a rescue therapy for adults with severe bleeding and refractory immune thrombocytopeniaMathilde Roumier, Sébastien Le Burel, Sylvain Audia, et al.
Rheumatology (Oxford, England)|May 15, 2018
Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonistsZelie Guitton, Louis Terriou, Jean-Christophe Lega, et al.
Pageof 6